Search the Newsreel

Citigroup poaches Charlet from Morgan Stanley to head French arm

Citigroup has hired Jean-Baptiste Charlet from Morgan Stanley to lead its French operations as Citi Country Officer & Banking Head, France. Charlet previously spent over 30 years at Morgan Stanley and is a graduate of HEC Paris. Citi stated that Charlet brings exceptional leadership, …

Citizens raises Nationwide Health Properties price target on strong Q2 results

Citizens has increased its price target for Nationwide Health Properties (NHP) to $21.00 from $18.00, maintaining a Market Outperform rating. This adjustment follows NHP's strong second-quarter 2026 results, which validated its SHOP-led growth strategy, with normalized funds available for distribution per share significantly exceeding …

Citizens reiterates Main Street Capital stock rating on strong earnings

Citizens maintained its Market Outperform rating and $70.00 price target on Main Street Capital (NYSE:MAIN) after the company reported strong second-quarter 2026 results. The company exceeded consensus estimates for net investment income and GAAP earnings per share, and its net asset value per share …

First Citizens BancShares, Inc. $FCNCA Shares Sold by Royal Bank of Canada

Citizens reiterates American Healthcare REIT stock rating on strong results

Citizens has reiterated its Market Outperform rating and $65.00 price target for American Healthcare REIT (NYSE:AHR) after the company surpassed Q2 2026 earnings estimates. The outperformance led management to raise its full-year 2026 normalized FFO guidance, signaling strong operating momentum and an accelerated external …

Sei Investments Co. Buys 22,964 Shares of Citi Trends, Inc. $CTRN

Sei Investments Co. significantly increased its stake in Citi Trends, Inc. by 101.7% in the first quarter, acquiring an additional 22,964 shares to hold a total of 45,536 shares valued at $1.97 million. This move comes as Citi Trends demonstrates strong financial performance, beating …

Contravisory Investment Management Inc. Has $1.22 Million Position in Citigroup Inc. $C

Contravisory Investment Management Inc. significantly increased its stake in Citigroup Inc. (NYSE:C) by over 6,200% in the second quarter, bringing its total holdings to $1.22 million. Institutional investors now own 71.72% of Citigroup. The bank also recently reported strong quarterly earnings, raised its dividend, …

Allied Private Wealth LLC Makes New Investment in Citigroup Inc. $C

Allied Private Wealth LLC has made a new investment in Citigroup Inc. (NYSE:C), acquiring 11,788 shares valued at approximately $1.62 million, making it their 16th largest holding. Citigroup recently reported strong quarterly earnings with EPS of $3.15 and revenue of $24.77 billion, exceeding analyst …

Citizens Inc (CIA) Earnings Forecast: Future EPS & Revenue Growth Estimates

How (CZFS) Movements Inform Risk Allocation Models

This article analyzes Citizens Financial Services Inc. (NASDAQ: CZFS) using AI models to inform risk allocation. It highlights strong sentiment supporting an overweight bias, notes the absence of resistance above the current price, and outlines three distinct trading strategies (Position Trading, Momentum Breakout, Risk …

Citigroup Inc. $C Stake Decreased by Oliver Luxxe Assets LLC

Oliver Luxxe Assets LLC reduced its stake in Citigroup Inc. by 20.7% in the second quarter, selling 24,110 shares but retaining 92,597 shares valued at $12.96 million. Despite this decrease by one institutional investor, other major funds increased their positions in Citigroup. The company …

Valeo Financial Advisors LLC Trims Stake in Citigroup Inc. $C

Valeo Financial Advisors LLC reduced its stake in Citigroup Inc. by 22.9% in the second quarter, selling 12,556 shares and retaining 42,360 shares valued at approximately $5.93 million. Despite this trimming, institutional investors collectively own 71.72% of Citigroup, and analysts generally maintain a "Moderate …

Birchbrook Inc. Has $1.12 Million Position in Citigroup Inc. $C

Birchbrook Inc. reduced its stake in Citigroup Inc. by 50% in the second quarter, now holding 7,975 shares valued at $1.12 million. Despite this, several other institutional investors increased their positions in Citigroup. The article also provides a summary of recent news affecting Citigroup, …

Avity Investment Management Inc. Buys 12,590 Shares of Citigroup Inc. $C

Avity Investment Management Inc. increased its stake in Citigroup Inc. by 10.9% in the second quarter, acquiring an additional 12,590 shares. This brings their total holdings to 127,653 shares valued at approximately $17.9 million. Citigroup recently reported strong quarterly earnings and revenue, exceeding analyst …

Dimensional Fund Advisors LP Sells 36,974 Shares of Citi Trends, Inc. $CTRN

Dimensional Fund Advisors LP has reduced its stake in Citi Trends, Inc. by 10.1%, selling 36,974 shares but still retaining 327,769 shares valued at approximately $14.2 million. This reduction comes as Citi Trends reported strong quarterly earnings, significantly exceeding analyst expectations with $0.91 EPS …

Citius Oncology Inc (CTOR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Citizens Financial Services (NASDAQ:CZFS) Cut to "Hold" at Wall Street Zen

Wall Street Zen downgraded Citizens Financial Services (CZFS) from "Buy" to "Hold," despite the company beating quarterly earnings and revenue expectations. Other analyst opinions were mixed, with Weiss Ratings upgrading and Zacks Research downgrading the stock. Institutional investors hold a significant portion of CZFS …

Citizens (CIA) Stock Sinks After Profit Turns To Loss

Citizens (CIA) stock dropped significantly after its Q2 2026 earnings report revealed a shift from profit to a small loss, contradicting previous investor expectations of improving profitability. Revenue declined year-on-year, and the net profit margin softened, reinforcing bearish arguments and raising concerns about the …

ETFs Investing in Citigroup Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Citigroup Inc. (A1H92V) stocks, providing key details for each fund such as market value, weight of Citigroup in the fund, issuer, management style, expense ratio, and AUM. The information aims to help investors identify …

Análisis y previsión de acciones de Citigroup Inc (C)

CITIZENS & NORTHERN CORP Q2 2026: Revenue $41.57M, EPS $0.79— 10-Q Summary

CITIZENS & NORTHERN CORP (CZNC) reported a strong second quarter for 2026, with revenue reaching $41.57M and EPS at $0.79. This significant year-over-year growth was primarily fueled by increased interest income and contributions from the October 2025 Susquehanna acquisition. The company saw substantial increases …

Citigroup (C) Stock Forecast: Strong Earnings Beat Meets Higher Spending Concerns as Recovery Tests $140

Citi Trends Inc (CTRN) Earnings Forecast: Future EPS & Revenue Growth Estimates

The article provides an earnings forecast for Citi Trends Inc (CTRN), indicating a current earnings forecast score of 8.00 and an average price target of $55.50 based on 2 analysts. It highlights an expected revenue of $205.52M for the next quarter and an anticipated …

Citizens Financial Services (CZFS) Stock Faces Credit Scrutiny Despite Stronger Profit Growth

Citizens Financial Services (CZFS) saw its stock dip by 2.3% despite reporting stronger profit growth, with Q2 2026 revenue up 9.9% and net income up 20.4% year-over-year. The market's reaction is attributed to concerns over the company's credit quality, specifically a rise in non-performing …

Becton, Dickinson and Company (NYSE:BDX) Given New $204.00 Price Target at Citigroup

Citigroup has raised its price target for Becton, Dickinson and Company (NYSE:BDX) to $204.00 from $198.00, maintaining a "buy" rating, which implies a potential upside of 15.56%. This adjustment follows Becton Dickinson's exceeding quarterly expectations with adjusted EPS of $3.23 and revenue of $4.98 …

Citizens & Northern Earnings Top Estimates on Revenue of $39.7 Million

Citizens & Northern Corp. (CZNC) reported strong second-quarter results, with net income of $14.1 million (79 cents per share) and revenue net of interest expense reaching $39.7 million, surpassing Street forecasts. The bank holding company, headquartered in Wellsboro, Pennsylvania, saw its total revenue, including …

First Citizens BancShares, Inc. $FCNCA Stock Position Lifted by Reinhart Partners LLC.

PensionDanmark Pensionsforsikringsaktieselskab Grows Stake in Citigroup Inc. $C

PensionDanmark Pensionsforsikringsaktieselskab increased its stake in Citigroup Inc. by 3.5% in the second quarter, bringing its total holdings to 424,914 shares valued at $59.5 million. This comes as Citigroup reported strong quarterly earnings, beating analyst estimates with EPS of $3.15 and a 14.5% year-over-year …

Citigroup (C) Stock May Be Reasonable As AI Banking Hopes Grow

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Citigroup stock has delivered a very strong 3 year run, yet current valuation checks and the intrinsic value estimate from the Excess Returns model …

NewEdge Advisors LLC Increases Position in Citigroup Inc. $C

NewEdge Advisors LLC significantly increased its stake in Citigroup Inc. by 20% in the first quarter, now holding 249,004 shares valued at $28.2 million. This move comes as Citigroup exceeded quarterly earnings expectations, reporting strong EPS and revenue growth, and raised its quarterly dividend. …

Empowered Funds LLC Sells 1,211 Shares of First Citizens BancShares, Inc. $FCNCA

Citizens (NYSE:CIA) Issues Earnings Results, Misses Expectations By $0.06 EPS

Citigroup Inc (C) Aktienanalyse & Prognose

Citigroup (NYSE:C) Downgraded to "Hold" Rating by Wall Street Zen

Citigroup (NYSE:C) was downgraded to a "Hold" rating by Wall Street Zen, though the broader analyst consensus remains a "Moderate Buy" with an average price target of $145.22. The bank recently reported stronger-than-expected quarterly earnings per share of $3.15 and authorized a $30 billion …

Análise e Previsão das Ações da Citigroup Inc (C)

Citius Pharmaceuticals Inc (CTXR) Earnings Forecast: Future EPS & Revenue Growth Estimates

Citius Pharmaceuticals Inc (CTXR) currently lacks an earnings forecast score, with the Biotechnology & Medical Research industry average at 8.10. Analysts have set an average price target of $5.00 for CTXR, with a high of $6.00 and a low of $4.00, indicating a potential …